Oramed Pharmaceuticals ORMP
NASDAQ ORMP
$4.48 -0.19 (-4.07%)
At close: Oct 1, 2026 · 4:00 PM EDT

Oramed Pharmaceuticals (ORMP) Depreciation & Amortization (CF) (2010 - 2026)

Updated

Oramed Pharmaceuticals' Depreciation & Amortization (CF) was $31,000 in Q2 2026, up 3.3% from $30,000 a year earlier and up 3.3% from the prior quarter.

Analysis

Oramed Pharmaceuticals (ORMP) Depreciation & Amortization (CF) (2010 - 2026) Analysis & Trends

On a trailing twelve-month basis, Oramed Pharmaceuticals' Depreciation & Amortization (CF) was $122,000 through Jun 30, 2026, down 14.7% year-over-year; for FY2025, it came in at $121,000, down 37.3% from FY2024.

  • Depreciation & Amortization (CF) shows a five-year compound annual growth rate of 76.8% (FY2020 to FY2025).
  • In earlier years, Depreciation & Amortization (CF) was $193,000 in FY2024 (-1.5%), $196,000 in FY2023 (+237.9%), $58,000 in FY2022 (+222.2%) and $18,000 in FY2021.
  • Quarterly Depreciation & Amortization (CF) has moved between $11,000 (Q1 2022) and $56,000 (Q1 2024) over five years.
  • Compared with a year earlier, Depreciation & Amortization (CF) was higher in 1 of the last eight quarters, with an average decline of 22.0%.
  • The best year-over-year quarter for Depreciation & Amortization (CF) over five years was Q3 2021 (growth of 833.3%); the worst was Q1 2025 (a decline of 46.4%).
  • Per Business Quant data, ORMP's Depreciation & Amortization (CF) in the three quarters before Q2 2026 was $30,000 (Q1 2026), $30,000 (Q4 2025) and $31,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.96 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 194.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 599.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 1.93 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 98.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 1.62 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 56.50 Mn
10 Oramed Pharmaceuticals 192.94 Mn 192.94 Mn - 31,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 31,000.00
Mar 31, 2026 30,000.00
Dec 31, 2025 30,000.00
Sep 30, 2025 31,000.00
Jun 30, 2025 30,000.00
Mar 31, 2025 30,000.00
Dec 31, 2024 31,000.00
Sep 30, 2024 52,000.00
Jun 30, 2024 54,000.00
Mar 31, 2024 56,000.00
Dec 31, 2023 53,000.00
Sep 30, 2023 54,000.00
Jun 30, 2023 52,000.00
Mar 31, 2023 37,000.00
Dec 31, 2022 17,000.00
Sep 30, 2022 15,000.00
Jun 30, 2022 15,000.00
Mar 31, 2022 11,000.00
Nov 30, 2021 12,000.00
May 31, 2021 28,000.00
API Access

Oramed Pharmaceuticals Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=ORMP&period=max&api_key=YOUR_API_KEY